Abstract:Objective: Stroke is a highly prevalent and disabling disease whose disease mechanisms are not fully understood. The discovery of disease-associated proteins with genetic evidence of pathogenicity provides an opportunity to identify new therapeutic targets. Method: We examined the observed and causal associations of thousands of plasma and inflammatory proteins that were measured using affinity-based proteomic assays. First, we pooled >3000 relevant proteins using a fixed-effects meta-analysis of 2 population-based studies involving 48,383 participants, then investigated the causal effects of stroke and its subtype-associated proteins by forward Mendelian randomization using cis-protein quantitative locus genetic tools identified from genome-wide association studies of these >48,000 individuals. To improve the accuracy of causal estimation, we implemented a systematic Mendelian randomization model that accounts for cascading imbalances between instruments and tested the robustness of causal estimation through multi-method analyses. To further validate the hypothesis that ginsenoside Rg1 monomer acts on the five protein targets screened for drug-targeted regulation, we conducted a comparative analysis of the mRNA (gene) expression levels of a limited number of genes in the brain tissues of different groups of SD rats. The druggability of the candidate proteins was investigated and the mechanism of action and potential targeting side effects were explored by Phenome-wide MR. Results: Six circulating proteins were identified to have a significant genetic association with stroke (PFDR < 0.05). For example, in patients with cardioembolic stroke, higher genetically predicted APRT was associated with a lower risk of cardioembolic stroke (ORivw [95 % CI] = 0.641 [0.517, 0.795]; P = 5.25 × 10-5, ORSMR [95 % CI] = 0.572, [0.397, 0.825], PSMR = 0.003). Mediation analyses suggested that atrial fibrillation, angina pectoris, and heart failure may mediate the association of CD40L, LIFR, and UPA with stroke. Molecular docking revealed promising interactions between the identified proteins and glycosides. Transcriptomic sequencing in animal models indicated that ginsenoside Rg1 may act through APRT, IL15RA, and VSIR pathways, with APRT showing significant variability in mRNA sequencing expression. Phenome-wide MR of the six target proteins showed an overwhelming predominance of PFDR > 0.05, indicating less toxicity. Conclusions: The present study provides genetic evidence to support the potential efficacy of targeting the three druggable protein targets for the treatment of stroke. This is achieved by triangulating population genomic and proteomic data. Furthermore, the study validates the pathway mechanisms by which APRT, IL15RA, and VSIR dock ginsenoside Rg1 in animal models. This will help to prioritize stroke drug development.

Viral isolates of intussusception in Nigerian infants.

Disulfidptosis and its Role in Peripheral Blood Immune Cells after a Stroke: A New Frontier in Stroke Pathogenesis

Ischemic Postconditioning Regulates New Cell Death Mechanisms in Stroke: Disulfidptosis

Exploring cuproptosis-related molecular clusters and immunological characterization in ischemic stroke through machine learning

Identification of diagnostic signatures for ischemic stroke by machine learning algorithm

Identification of hypoxia-related genes and exploration of their relationship with immune cells in ischemic stroke

Integrative multi-omics approach using random forest and artificial neural network models for early diagnosis and immune infiltration characterization in ischemic stroke

Identification of Circulating Immune Landscape in Ischemic Stroke based on Bioinformatics Methods

Integrating machine learning and single-cell transcriptomic analysis to identify potential biomarkers and analyze immune features of ischemic stroke

Identification of novel biomarkers and immune infiltration characteristics of ischemic stroke based on comprehensive bioinformatic analysis and machine learning

Discovery and validation of molecular patterns and immune characteristics in the peripheral blood of ischemic stroke patients

Identification and validation of platelet-related diagnostic markers and potential drug screening in ischemic stroke by integrating comprehensive bioinformatics analysis and machine learning

Is Immune Suppression Involved in the Ischemic Stroke? A Study Based on Computational Biology

Exploring biomarkers for ischemic stroke through integrated microarray data analysis

Identification of Dysregulated Mechanisms and Potential Biomarkers in Ischemic Stroke Onset

Identification of cell death-related biomarkers and immune infiltration in ischemic stroke between male and female patients

Bioinformatics analysis and in vivo validation of ferroptosis-related genes in ischemic stroke

Multi-omics combined to investigate potential druggable therapeutic targets for stroke: A systematic Mendelian randomization study and transcriptome verification

Machine learning identification and immune infiltration of disulfidptosis‐related Alzheimer's disease molecular subtypes

Unraveling the molecular interplay of ferroptosis and immune regulation in stroke pathogenesis: A comprehensive bioinformatics analysis

Identification of endoplasmic reticulum stress genes in human stroke based on bioinformatics and machine learning